Details of the Drug

General Information of Drug (ID: DMR2BZ7)

Drug Name

CM4620

Synonyms

CM-4620; 1713240-67-5; CM4620; SCHEMBL18038390; GTPL10087; CM4620; EX-A1898; BCP29536; CM 4620; compound I [WO2016138472A1]; SB18686; AK549808; HY-101942; CS-0022201

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C19H11ClF3N3O3
Canonical SMILES: CC1=C(C(=CC=C1)F)C(=O)NC2=NC=C(N=C2)C3=CC4=C(C=C3Cl)OC(O4)(F)F
InChI: 1S/C19H11ClF3N3O3/c1-9-3-2-4-12(21)17(9)18(27)26-16-8-24-13(7-25-16)10-5-14-15(6-11(10)20)29-19(22,23)28-14/h2-8H,1H3,(H,25,26,27)
InChIKey: QQMKTHUGOQDEIL-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 122507647
TTD ID: D05QIK

References

1	ClinicalTrials.gov (NCT04345614) A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia. U.S. National Institutes of Health.